scholarly journals Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials: Table 1.

2015 ◽  
Vol 61 (4) ◽  
pp. 666-667 ◽  
Author(s):  
Patrick R. Harrington ◽  
Damon J. Deming ◽  
Takashi E. Komatsu ◽  
Lisa K. Naeger
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Antiviral Treatment ◽  
Hepatitis C Virus Rna ◽  
Direct Acting Antiviral ◽  
Virus Rna ◽  
Direct Acting ◽  
Rna Levels

scholarly journals Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0122232 ◽  
Author(s):  
Behzad Hajarizadeh ◽  
Bart Grady ◽  
Kimberly Page ◽  
Arthur Y. Kim ◽  
Barbara H. McGovern ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Acute Infection ◽  
Hepatitis C Virus Rna ◽  
Virus Rna ◽  
Rna Levels

Changes in Serum Level of Autotaxin with Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Khaled Mohamed Hussein Abdelwahab ◽  
Shereen Abou Bakr Saleh ◽  
Ghada Abdelrahman Ahmed ◽  
Asmaa Mady Gomaa Mady
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Serum Level ◽  
Antiviral Therapy ◽  
Chronic Hepatitis C ◽  
Antiviral Treatment ◽  
Post Treatment ◽  
Direct Acting Antiviral ◽  
Direct Acting

Abstract Background Hepatitis C virus virus is global health burden and major health hazard in Egypt, since the virus is the etiological factor of chronic hepatitis. Hepatitis C virus (HCV) accounts for approximately 15%-20% cases of acute hepatitis. After acute infection, around 50% to 80% of HCV patients will develop chronic infection. Approximately, HCV infects 170 million individuals worldwide). Chronic hepatitis C (CHC) patients are at high risk to develop lifethreatening complications, including cirrhosis in 20% of cases and hepatocellular carcinoma. Objectives The aim of this study was to validate Changes in serum level of autotaxin in patients with chronic hepatitis C before and after antiviral treatment. Patients and methods This study was designed as a prospective observational cohort study to evaluate Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C before (baseline) and after (sustained virologic response week 12) treatment. This prospective study was conducted on 48 chronic HCV infected patients eligible for antiviral treatment with direct acting antivirals, agreeable to regular follow up, recruited from Hepatology and virology outpatient clinic at DMNI (Damanhour Medical National Institute) during the period from September 2018 till Mars 2019. Results This study showed that Autotaxin level significantly decreased from baseline to 12 weeks post-treatment. ATX therefore represents a novel non-invasive biomarker for liver fibrosis and a prognostic indicator of disease activity. Conclusion Serum Autotaxin was found to be higher in chronic hepatitis c and ATX levels became significantly decreased from baseline to 12 weeks post-treatment with direct acting antiviral drugs in patients achieving a SVR.

scholarly journals Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus

2018 ◽  
Vol 12 (3) ◽  
pp. 213-217
Author(s):  
Masako Okada ◽  
Hoang Hai ◽  
Akihiro Tamori ◽  
Sawako Uchida-Kobayashi ◽  
Masaru Enomoto ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Antiviral Treatment ◽  
Recombinant Hepatitis ◽  
Direct Acting Antiviral ◽  
Genotype 2 ◽  
Direct Acting

Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures

2018 ◽  
Vol 25 (11) ◽  
pp. 1251-1259 ◽  
Author(s):  
Y. Jeong ◽  
B. Jin ◽  
H. W. Lee ◽  
H. J. Park ◽  
J. Y. Park ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Antiviral Treatment ◽  
Direct Acting Antiviral ◽  
Direct Acting

scholarly journals Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method

Hepatology ◽  
2007 ◽  
Vol 46 (1) ◽  
pp. 22-31 ◽  
Author(s):  
Stéphane Chevaliez ◽  
Magali Bouvier-Alias ◽  
Rozenn Brillet ◽  
Jean-Michel Pawlotsky
Keyword(s):  
Polymerase Chain Reaction ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Real Time ◽  
Hepatitis C Virus Rna ◽  
Chain Reaction ◽  
Virus Rna ◽  
Polymerase Chain ◽  
Rna Levels

scholarly journals Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

Hepatology ◽  
2018 ◽  
Vol 67 (4) ◽  
pp. 1253-1260 ◽  
Author(s):  
Fred Poordad ◽  
Stanislas Pol ◽  
Armen Asatryan ◽  
Maria Buti ◽  
David Shaw ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Failure ◽  
Antiviral Treatment ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document